Articles by Ronald Wapner, MD

Risk Factors for Postcesarean Maternal Infection in a Trial of Extended-Spectrum Antibiotic Prophylaxis

Boggess, Kim A.; Tita, Alan; Jauk, Victoria; More

Obstetrics & Gynecology. 129(3):481-485, March 2017.

  • Correction

Expanded Carrier Screening in Reproductive Medicine—Points to Consider: A Joint Statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine

Edwards, Janice G.; Feldman, Gerald; Goldberg, James; More

Obstetrics & Gynecology. 125(3):653-662, March 2015.

Implementation of a National Nuchal Translucency Education and Quality Monitoring Program

D'Alton, Mary E.; Fuchs, Karin M.; Abuhammad, Alfred; More

Obstetrics & Gynecology. 123(1):149-154, January 2014.

Sequential Pathways of Testing After First-Trimester Screening for Trisomy 21

Platt, Lawrence D.; Greene, Naomi; Johnson, Anthony; More

Obstetrics & Gynecology. 104(4):661-666, October 2004.

Randomized Clinical Trial of Metronidazole Plus Erythromycin to Prevent Spontaneous Preterm Delivery in Fetal Fibronectin–Positive Women

Andrews, William W.; Sibai, Baha M.; Thom, Elizabeth A.; More

Obstetrics & Gynecology. 101(5):847-855, May 2003.